Marché nord-américain de l’IA en bioinformatique – Tendances et prévisions du secteur jusqu’en 2029

Analyse et taille du marché de l'IA en bioinformatique en Amérique du Nord

La réduction du coût du séquençage génétique a renforcé la demande du marché. L'augmentation des dépenses de santé pour de meilleurs services de santé contribue également à la croissance du marché. Les principaux acteurs du marché se concentrent sur le lancement et l'approbation de divers services au cours de cette période cruciale. En outre, la demande croissante en bioinformatique et l'augmentation du financement public-privé pour la bioinformatique contribuent également à la demande croissante du marché.

Le marché nord-américain de l'IA en bioinformatique connaît une croissance au cours de l'année de prévision en raison de l'augmentation du nombre d'acteurs du marché et de la disponibilité de services avancés. Parallèlement à cela, les fabricants sont engagés dans des activités de R&D pour lancer de nouveaux services sur le marché. Les progrès croissants de la technologie bioinformatique stimulent encore la croissance du marché. Cependant, le coût élevé des instruments et les problèmes de cybersécurité en bioinformatique pourraient entraver la croissance du marché nord-américain de l'IA en bioinformatique au cours de la période de prévision.

Les progrès techniques et la modernisation croissants, ainsi que les initiatives stratégiques des acteurs du marché, offrent des opportunités de marché. Cependant, le manque de professionnels qualifiés pour mettre en œuvre la technologie bioinformatique basée sur l'IA et les défis liés à la mise en œuvre de la technologie bioinformatique dans les laboratoires cliniques constituent des défis majeurs pour la croissance du marché.

Data Bridge Market Research estime que le marché nord-américain de l'IA en bioinformatique devrait atteindre une valeur de 19 677,40 millions USD d'ici 2030, à un TCAC de 45,2 % au cours de la période de prévision. Le rapport sur le marché nord-américain de l'IA en bioinformatique couvre également de manière exhaustive l'analyse des prix, l'analyse des brevets et les avancées technologiques.     

Market Definition

The North America AI in bioinformatics market refers to the sector within the North American region where artificial intelligence (AI) technologies are applied in the field of bioinformatics. Bioinformatics involves the use of computational methods and techniques to analyze and interpret biological data, such as genomic sequences, protein structures, and large-scale biological experiments.

Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

There are scores of branches of biology to specialize in, from genetics, toxicology, mycology, and radiobiology. And out of the many, bioinformatics is one of the intriguing fields that enables identifying, evaluating, storing, and retrieving biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data such as DNA sequencing, protein analysis, evolutionary genetics, and others.

North America AI in Bioinformatics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Reduction in the Genetic Sequencing Cost

The strong demand for decreasing the cost of genomics and biomarker prediction has contributed to the creation of high-throughput genome sequencing, which often goes by next-generation sequencing (NGS). Thousands or millions of sequences in a single bioinformatics cycle are generated simultaneously. Dramatic upgrades to industrial NGS technologies have resulted in dramatic cutbacks in cost-per-base DNA sequencing. Thus, the main sequencing techniques have recently become the key research subject, with sample design optimization taking a secondary function.

With its parallel capacity to handle hundreds of millions of DNA templates, next-generation sequencing has greatly improved sequencing efficiency and reduced sequencing costs. Moreover, the cost of bioinformatics has decreased dramatically since the completion of the Human Genome Project, outpacing Moore's Law. Illumina has helped reduce the cost of bioinformatics instrumentation through continuous innovation, allowing the USD 1000 human genome.

• Growing Demand for Bioinformatics

As genomics-focused pharmacology continues to play a greater role in treating various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology.

NGS offers advantages in accuracy, sensitivity, and speed compared to traditional methods that have the potential to make a significant impact on the field of oncology. Because NGS can assess multiple genes in a single assay, the need to order multiple tests to identify the causative mutation is eliminated. AI in bioinformatics is important for data management in modern biology and medicine.

The increasing use of bioinformatics is driven by the explosion of biological data, the need for data integration and analysis, its applications in drug discovery and personalized medicine, its contribution to understanding complex biological systems, and its role in evolutionary biology and phylogenetic. Bioinformatics plays a significant role in advancing biological research, improving healthcare, and addressing various challenges in the life sciences.

Opportunity

• Rise in Healthcare Expenditure

The rise in healthcare expenditure by governments has been observed in many countries around the world. Healthcare expenditure has increased worldwide as people's disposable income in various countries increases. Moreover, to accomplish the population requirements, government bodies, and healthcare organizations are taking the initiative by accelerating healthcare expenditure. As populations age, there is an increased demand for healthcare services, including chronic disease management, long-term care, and end-of-life care. The elderly population tends to require more healthcare resources and services, leading to higher healthcare expenditures. There are some instances where many government organizations improved the solid funding for healthcare which boosted the healthcare market and it made a significant opportunity for North America AI in bioinformatics market.

Restraint/Challenge

• Cybersecurity Concerns in Bioinformatics

Bioinformatics datasets contain sensitive information, including genomic data, personal health information, and research data. If unauthorized individuals gain access to this data through breaches in cybersecurity defences, it can lead to privacy violations, identity theft, or misuse of the data.

However, the increasing computerization of DNA technology and biotechnology, more generally, raises new bio-cyber security concerns. Vulnerabilities typically associated with traditional computer systems – such as the processing of untrusted input, side-channel leaks, poor authentication, falsified data, and vulnerabilities in cyber-physical systems -- now exist in biotechnology. The emerging bio-cyber security threats have threatened the DNA-information systems in bioinformatics.

Post-COVID-19 Impact on North America AI in Bioinformatics Market

The AI in bioinformatics industry noted a decrease in demand due to the lockdown and COVID-19. Governmental laws, as manufacturing facilities and services were closed. COVID-19 created a major impact on various industries as almost every country has opted for the shutdown of every facility except the ones dealing in the essential goods segment. The government has taken some strict actions such as the shutdown of facilities and sale of non-essential goods, blocked international trade, and many more to prevent the spread of COVID-19. This boosted the North America AI in bioinformatics market, as the consumers were availing insurance to avoid huge capital payments at hospitals just in case of medical needs. Hence, COVID-19 impacted positively North America AI in the bioinformatics market.

Recent Developments

• In September 2022, Elucidata, a TechBio company, successfully raised USD 16 million in a Series A fundraising round. The funding was led by Eight Roads Ventures. The company plans to utilize the newly acquired capital to enhance product capabilities in translational drug research and related markets. Additionally, the funds will support the expansion of go-to-market initiatives and enable the company to grow its operations globally.
• In January 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, a leading innovation-driven international healthcare group in China, and Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and Development Company. The Company entered into a collaboration agreement to advance the discovery and development of drugs targeting several targets globally through AI technology. This has helped the company expand its market product portfolio and increase its global presence

North America AI in Bioinformatics Market Scope

North America AI in bioinformatics market is segmented on the basis of offering, type, product and services, application, and sector. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Offering

• Services
• Software
• Others

On the basis of offering, the North America AI in bioinformatics market is segmented into services, software and others.   

Type

• Machine Learning
•  Deep Learning
•  Others

On the basis of type, North America AI in bioinformatics market is segmented into machine learning, deep learning, and others.

Products and Services

• Bioinformatics Services
• Bioinformatics Platforms
• Knowledge Management Tools

On the basis of product and services, the North America AI in bioinformatics market is segmented into bioinformatics services, bioinformatics platforms and knowledge management tools.

Application

• Genomics
• Chemoinformatics & Drug Design
• Proteomics
• DNA Sequencing
• System Biology
• Transcriptomics
• Text Mining
• Microarrays
• Metabolomics
• Others

On the basis of the application, the North America AI in bioinformatics market is segmented into genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics and others.

Sector

• Medical Biotechnology
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology
• Others

On the basis of the sector, the North America AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others.

North America AI in Bioinformatics Market Regional Analysis/Insights

North America AI in bioinformatics market is analyzed, and market size insights and trends are provided by country, offering, type, products and services, application, and the sector as referenced above.

The countries covered in the North America AI in bioinformatics market report are U.S., Canada, and Mexico. U.S. dominates in the North America region due to the high demand for AI in bioinformatics devices. Additionally, The U.S. has a robust R&D ecosystem with a significant investment in scientific research. Leading universities and research institutions in the country have made substantial contributions to the field of bioinformatics, including the application of AI techniques.

La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, ainsi que des études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour chaque pays. En outre, la présence et la disponibilité des marques nord-américaines et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.   

Paysage concurrentiel et analyse des parts de marché de l'IA en bioinformatique en Amérique du Nord

Le paysage concurrentiel du marché nord-américain de l'IA en bioinformatique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Amérique du Nord, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché nord-américain de l'IA en bioinformatique.

Français Certains des principaux acteurs opérant sur le marché nord-américain de l'IA en bioinformatique sont JADBio & Gnosis Data Analysis, SOPHiA GENETICS, Biomax Informatics AG, DNASTAR, Ardigen, QIAGEN, Source BioScience., NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific Inc., CelbridgeScience., Dassault Systemes Fios Genomics, Insilico Medicine, Strand Life Sciences, Paige AI, Inc., SomaLogic Operating Co., Inc., iNDX. Ai., et Elucidata entre autres.

SKU-69032